3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Lung Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cardiotoxicity
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Adenocarcinoma Of Esophagus
1
Interventions
Doxorubicin
5
pazopanib
4
Ifosfamide
3
pembrolizumab
2
Sunitinib
2
Radiotherapy, Conformal
2
Radiotherapy
2
tremelimumab
1
temsirolimus
1
sintilimab
1
saracatinib
1
sapanisertib
1
romidepsin
1
olaratumab
1
liposomal doxorubicin
1
indolepropanol phosphate
1
eribulin
1
durvalumab
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Sorafenib
1
Razoxane
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Polymerase Chain Reaction
1
Observation
1
Nivolumab
1
Neoadjuvant Therapy
1
Methotrexate
1
MLN 8237
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Histiocytoma, Malignant Fibrous
×
Mass Spectrometry
×
Clear all
No trials found.